Response to 'Withdrawal of life-sustaining treatment in the first year of life'
We thank Drs Bosslet and Helft for continuing the conversation on the withdrawal of support from critically ill infants. It is important to understand that in presenting essentially a case report of six patients, our goal was to describe the Medical Appropriateness Review Committee (MARC) and the kind of cases referred to it, rather than critique the actual cases.
We agree with Boslett and Helft that race can be an important consideration, and we reported our demographic data appropriately in the results section as it might be important to readers. In Houston, 70% of the population is African-American and Hispanic, and national data consistently show that African-Americans are disproportionately represented in prematurity and other medical problems requiring admission to an Neonatal Intensive Care Unit (NICU). The admission population of our (NICU) during the study period was 41% African-American, 25% Hispanic, 31% White and 3% others. For Pediatric Intensive Care Unit (PICU) admissions, 24% were African-American, 33% Hispanic, 33% White and 1% others. With such small numbers referred to the MARC from each unit, it is difficult to show statistical confidence, but we share concerns of over-representation of African-Americans in the cases referred to the MARC.
It is important to note that the six individual cases were ascertained by their referral to the MARC; we did not systematically review the remaining thousands of admissions to the NICU and PICU over the study period. Families or caregivers in any of the six cases did not raise race as an implicit or explicit issue. We do reaffirm that we saw no evidence that either the decisions by the physicians to limit treatment or the decisions of the MARC were influenced by considerations of race, ethnicity, insurance or socioeconomic status.
We stated, 'a major part of the solution to these conflicts lies in improved communication. ' 1 We feel that effective communication is the key to avoid such conflicts. Recognizing that much communication occurred before referral to the MARC, we found no evident difference between the pre-referral communication process involving these six patients that distinguishes them from the thousands of others that did not result in referral to the MARC. However, our methodology was not designed to examine more subtle influences on case referral to the MARC.
Bosslet and Helft cite Truog's statements that 'physicians often communicate poorly, and this deficiency is exacerbated when the communication must occur across the gaps created by language, class and culture'. 2 They also mention a study by Azoulay et al. that found that up to half of the patients' families in an ICU environment had a poor understanding of either the diagnosis, prognosis or the treatment their family member was receiving. Although these statements may be true, these issues would seem to us to apply more to the circumstances leading to referral to MARC than to the MARC process itself. By the time of referral to MARC, families and caregivers were able to articulate their understandings of the facts and values. For the reasons given in our publication, we believe that the MARC process offered significantly improved communication and protections for patients and families. However, although communication is certainly important, we also feel it is naive to believe that all the conflicts about patient's care can be resolved by better communication. It is clear that communication alone cannot be expected to resolve fundamentally different values or understandings of medical facts.
In the final analysis, we believe that reviews of the appropriateness of medical care are centered on facts and values. Although race may be a factor in developing a person's values, it is the conflict of facts and values that brings cases to ethical discussion. The MARC is an independent, systematic process designed to resolve an irreconcilable conflict about medical treatment. Although it is important to understand why individuals and populations are led to their values, the MARC's job is to review the individual circumstances as they are, and independently reach a concrete recommendation based on the medical facts of the case.
Our intention was to describe our experience with Texas Advance Directives Act (TADA) and Memorial Hermann's novel approach to these issues with the formation of the MARC. We continue to believe that the structure and procedures of the MARC provide a consistent and thoughtful independent review of the medical facts of each case, enhance discussion of facts and values through systematically good communications, and ultimately lead to an actionable conclusion. 
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